RE:RE:If Medipharm continues to improve QOQand therein lies the conundrum for shareholders QC1
Management has publicly stated they believe the current market cap of Medipharm is very undervalued, yet short of quarterly required disclosure they are relatively selective with any positive announcements even though from the outside looking in, it would appear there are a lot of moving parts that could be promoted as positive events to shareholders.
Something as simple as including an approx monetary expectation from the Hope facility, as that will when sold add $$$ to the treasury. Got to be worth something considering the price VIVO paid for Canna Farms a few short years ago.
I have no plans on selling my holdings with Labs as they appear to be steering the ship towards profitability, but there is no question it has been a frustrating ride the past few years especially when considering the huge global playing field to promote Medipharm specific medical products.
I like your thoughts of $2-3 QC1 Cheers to positive vibes for management meeting projections and expectations as we are not the only ones who see Labs as currently undervalued :-)
https://www.theglobeandmail.com/investing/markets/stocks/LABS-T/pressreleases/26716372/medipharm-labs-top-10-undervalued-drug-manufacturers-industry-stocks-labs/